These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27693871)

  • 1. Supratherapeutic anti-factor Xa levels in patients receiving prophylactic doses of enoxaparin: A case series.
    Pannucci CJ; Varghese TK; Graves KK; Prazak AM
    Int J Surg Case Rep; 2016; 28():114-116. PubMed ID: 27693871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
    Pannucci CJ; Prazak AM; Scheefer M
    Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Stratification for Supratherapeutic Peak Anti-Xa Levels in Adult Patients on Therapeutic Enoxaparin.
    Sheredy SA; Stone AC; Mostafavifar AM; Mostafavifar LG; Smith RM; Doepker BA
    Ann Pharmacother; 2024 Apr; 58(4):366-374. PubMed ID: 37515524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.
    Pannucci CJ; Hunt MM; Fleming KI; Prazak AM
    Plast Reconstr Surg; 2017 Oct; 140(4):815-822. PubMed ID: 28953735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
    Rowan BO; Kuhl DA; Lee MD; Tichansky DS; Madan AK
    Obes Surg; 2008 Feb; 18(2):162-6. PubMed ID: 18165884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis.
    Marshall AM; Trussell TM; Yee AM; Malone MP
    Thromb Res; 2021 Jul; 203():117-120. PubMed ID: 33992874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients.
    Cronin BJ; Godat LN; Berndtson AE; Pham A; Kolan S; Box K; Lee JG; Costantini TW
    Burns; 2019 Jun; 45(4):818-824. PubMed ID: 30827851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratherapeutic anticoagulation from low-molecular-weight heparin in lung transplant recipients.
    Singer JP; Huang MY; Hui C; Blanc PD; Boettger RF; Golden J; Watkins K; Hoopes C; Leard LE
    J Heart Lung Transplant; 2010 Sep; 29(9):1009-13. PubMed ID: 20627627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study evaluating target attainment of anti-Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients.
    Chanas T; Gibson G; Langenstroer E; Herrmann DJ; Carver TW; Alexander K; Chui SHJ; Rein L; Ha M; Maynard KM; Bamberg K; O'Keefe M; O'Brien M; Gonzalez MC; Hobbs B; Pajoumand M; Peppard WJ
    Pharmacotherapy; 2024 Mar; 44(3):258-267. PubMed ID: 38148134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
    Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
    J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trauma patients with lower extremity and pelvic fractures: Should anti-factor Xa trough level guide prophylactic enoxaparin dose?
    Dhillon NK; Smith EJT; Gillette E; Mason R; Barmparas G; Gewertz BL; Ley EJ
    Int J Surg; 2018 Mar; 51():128-132. PubMed ID: 29367044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.
    Simone EP; Madan AK; Tichansky DS; Kuhl DA; Lee MD
    Surg Endosc; 2008 Nov; 22(11):2392-5. PubMed ID: 18594915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of postpartum anti-Xa levels following enoxaparin administration to prevent venous thromboembolism using 2 weight-based protocols: a randomized controlled trial.
    Haj R; Massalha M; Eitam H; Kassabri R; Yefet E; Nachum Z
    Am J Obstet Gynecol MFM; 2023 Aug; 5(8):100988. PubMed ID: 37156466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day Bleeding.
    Pannucci CJ; Fleming KI; Momeni A; Prazak AM; Agarwal J; Rockwell WB
    Plast Reconstr Surg; 2018 Jun; 141(6):1580-1590. PubMed ID: 29608533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients With Morbid Obesity.
    Thompson-Moore NR; Wanat MA; Putney DR; Liebl PH; Chandler WL; Muntz JE
    Clin Appl Thromb Hemost; 2015 Sep; 21(6):513-20. PubMed ID: 25601898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Xa activity after enoxaparin prophylaxis in hospitalized patients weighing less than fifty-five kilograms.
    Rojas L; Aizman A; Ernst D; Acuña MP; Moya P; Mellado R; Cerda J
    Thromb Res; 2013; 132(6):761-4. PubMed ID: 24521789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraprophylactic Anti-Factor Xa Levels Are Associated with Major Bleeding in Neurosurgery Patients Receiving Prophylactic Enoxaparin.
    May CC; Cua S; Smetana KS; Powers CJ
    World Neurosurg; 2022 Jan; 157():e357-e363. PubMed ID: 34655821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.